載入...
Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis
INTRODUCTION: Triple negative breast cancer (TNBC) has a poorer survival, despite a higher response rate to neoadjuvant chemotherapy. The purpose of this study was to identify the predictive or prognostic value of Ki-67 among patients with TNBC treated with neoadjuvant chemotherapy, and the role of...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
BioMed Central
2011
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3219180/ https://ncbi.nlm.nih.gov/pubmed/21366896 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr2834 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|